Detalhe da pesquisa
1.
Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
N Engl J Med
; 364(3): 205-14, 2011 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21208101
2.
Carcinoma en cuirasse.
Proc (Bayl Univ Med Cent)
; 32(2): 263-265, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31191149
3.
Clinico-radiologic features and management of hematological tumors in the breast: a case series.
Breast Cancer
; 26(2): 244-248, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30229499
4.
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Cancer Med
; 7(6): 2288-2298, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582557
5.
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
Clin Breast Cancer
; 7(11): 850-6, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18269774
6.
Two cancers in one: breast carcinoma with underlying melanoma.
Proc (Bayl Univ Med Cent)
; 30(3): 316-318, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28670070
7.
Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
J Clin Oncol
; 21(6): 1007-14, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637464
8.
Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
Clin Breast Cancer
; 5(2): 142-7, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15245619
9.
A medical student perspective on solutions for burnout.
Proc (Bayl Univ Med Cent)
; 32(3): 452-455, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384221
10.
Our experience as a Health Volunteers Overseas-sponsored team in Huê´, Vietnam.
Proc (Bayl Univ Med Cent)
; 26(2): 137-41, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23543968
11.
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials.
J Clin Oncol
; 28(21): 3416-21, 2010 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20530275
12.
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
J Clin Oncol
; 27(8): 1177-83, 2009 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19204201
13.
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
Lancet Oncol
; 8(3): 203-11, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17329190
14.
Inflammatory breast cancer: the experience of Baylor University Medical Center at Dallas.
Proc (Bayl Univ Med Cent)
; 24(2): 86-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21566749
15.
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
J Clin Oncol
; 24(34): 5381-7, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17135639
16.
Maintenance of Certification: My Perspective.
J Oncol Pract
; 3(3): 159-161, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29455608